bimatoprost lens (LL-BMT1) / MediPrint Ophthalmics - LARVOL DELTA

Study of LL-BMT1 in Patients With Elevated Intraocular Pressure (clinicaltrials.gov) - P2a; N=5; Completed; Sponsor: MediPrint Ophthalmics, Inc.; Recruiting ➔ Completed; Trial completion date: Jan 2022 ➔ Feb 2021; Trial primary completion date: Jan 2022 ➔ Feb 2021

Clinical • Trial completion • Trial completion date • Trial primary completion date • Glaucoma • Ophthalmology

Study of LL-BMT1 in Patients With Elevated Intraocular Pressure (clinicaltrials.gov) - P2a; N=5; Recruiting; Sponsor: MediPrint Ophthalmics, Inc.

Clinical • New P2a trial • Glaucoma • Hypertension • Ophthalmology